#BEGIN_DRUGCARD DB03277

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
1109-28-0

# ChEBI_ID:
27931

# Chemical_Formula:
C18H32O16

# Chemical_IUPAC_Name:
(2S,3R,4S,5S,6R)-2-{[(2S,3S,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2S,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Amylotriose

# HET_ID:
MLR

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C18H32O16/c19-1-4-7(22)8(23)12(27)17(31-4)34-15-6(3-21)32-18(13(28)10(15)25)33-14-5(2-20)30-16(29)11(26)9(14)24/h4-29H,1-3H2/t4-,5+,6+,7-,8+,9-,10-,11-,12-,13-,14-,15-,16-,17+,18+/m1/s1

# InChI_Key:
InChIKey=FYGDTMLNYKFZSV-BYLHFPJWSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C01835

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3277

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
504.4371

# Molecular_Weight_Mono:
504.169034976

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1URS

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.7

# Predicted_LogS:
0.04

# Predicted_Water_Solubility:
5.54e+02 g/l

# Primary_Accession_No:
DB03277

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936192

# PubChem_Substance_ID:
46507051

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02187

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@H]3CO)O[C@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:05 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AJ252161

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
malE

# Drug_Target_1_Gene_Sequence:
>1284 bp
GTGTCGGTGAGGAGATGGGGAATCGTATCGACAGGTGTGGCCGCGCTCGTGTTGGCGGGC
GGAGCCATCGCGGGCTGTGGAACCTCGAACGGTGGTCAAAACACGTCTCCTTCCACGAGC
TCGTCGAGCGCCAAAGGGGAGGCAAGCGCTCTGCCCAAAGGGCAGACCATCACCGTTTGG
TCGTGGCAGACAGGGCCGGAGTTGCAAGACGTGAAGCAGATCGCCGCTCAGTGGGCAAAG
GCTCATGGGGACAAGGTCATTGTCGTCGACCAAAGCTCCAATCCGAAGGGATTCCAGTTC
TACGCCACGGCGGCTCGCACGGGCAAGGGGCCTGATGTCGTGTTTGGAATGCCGCACGAC
AACAATGGCGTTTTCGCAGAAGAAGGATTGATGGCGCCGGTACCGTCTGGCGTGCTCAAC
ACGGGTCTCTATGCACCTAATACGATCGACGCCATCAAGGTCAACGGCACGATGTACTCG
GTGCCAGTATCCGTTCAGGTCGCGGCAATCTACTACAACAAAAAGCTTGTGCCGCAGCCA
CCGCAGACATGGGCCGAATTCGTGAAAGACGCAAATGCACATGGCTTCATGTATGACCAA
GCGAATCTTTACTTCGATTACGCCATTATCGGCGGCTATGGCGGGTATGTGTTCAAGGAC
AACAACGGCACACTCGACCCGAACAACATAGGTCTTGACACACCGGGGGCTGTGCAGGCT
TACACGCTGATGAGGGATATGGTCTCCAAGTATCACTGGATGACCCCGAGCACGAATGGC
TCTATCGCGAAGGCTGAGTTTCTGGCTGGGAAGATTGGTATGTACGTGAGTGGCCCATGG
GACACGGCGGATATTGAGAAGGCCAAAATTGACTTCGGTGTAACGCCATGGCCCACCTTG
CCGAACGGCAAGCATGCCACGCCCTTCTTAGGCGTTATCACGGCATTTGTGAACAAGGAG
TCCAAGACCCAGGCAGCTGACTGGAGCCTTGTTCAAGCGTTGACCAGTGCGCAGGCGCAG
CAAATGTACTTCAGAGATTCCCAGCAGATTCCTGCGCTCTTGTCTGTGCAGAGGTCGAGC
GCCGTCCAGTCGAGCCCAACCTTTAAAGCGTTCGTCGAACAGTTGCGCTACGCGGTACCG
ATGCCCAACATTCCGCAAATGCAGGCCGTGTGGCAAGCAATGAGCATCCTGCAGAATATC
ATTGCGGGCAAGGTGTCACCAGAGCAGGGTGCGAAGGATTTTGTGCAAAACATTCAAAAA
GGCATCATGGCACAAGGATCCTGA

# Drug_Target_1_General_Function:
Involved in maltose transmembrane transporter activity

# Drug_Target_1_General_References:
11053372	Hulsmann A, Lurz R, Scheffel F, Schneider E: Maltose and maltodextrin transport in the thermoacidophilic gram-positive bacterium Alicyclobacillus acidocaldarius is mediated by a high-affinity transport system that includes a maltose binding protein tolerant to low pH. J Bacteriol. 2000 Nov;182(22):6292-301.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
5209

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
45674

# Drug_Target_1_Name:
Maltose binding protein

# Drug_Target_1_Number_of_Residues:
427

# Drug_Target_1_PDB_ID:
1URS

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01547	SBP_bac_1

# Drug_Target_1_Protein_Sequence:
>Maltose binding protein
MSVRRWGIVSTGVAALVLAGGAIAGCGTSNGGQNTSPSTSSSSAKGEASALPKGQTITVW
SWQTGPELQDVKQIAAQWAKAHGDKVIVVDQSSNPKGFQFYATAARTGKGPDVVFGMPHD
NNGVFAEEGLMAPVPSGVLNTGLYAPNTIDAIKVNGTMYSVPVSVQVAAIYYNKKLVPQP
PQTWAEFVKDANAHGFMYDQANLYFDYAIIGGYGGYVFKDNNGTLDPNNIGLDTPGAVQA
YTLMRDMVSKYHWMTPSTNGSIAKAEFLAGKIGMYVSGPWDTADIEKAKIDFGVTPWPTL
PNGKHATPFLGVITAFVNKESKTQAADWSLVQALTSAQAQQMYFRDSQQIPALLSVQRSS
AVQSSPTFKAFVEQLRYAVPMPNIPQMQAVWQAMSILQNIIAGKVSPEQGAKDFVQNIQK
GIMAQGS

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-26

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q9RHZ6

# Drug_Target_1_SwissProt_Name:
Q9RHZ6_ALIAC

# Drug_Target_1_Synonyms:
Maltose binding protein precursor

# Drug_Target_1_Theoretical_pI:
8.73

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Not Available

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
AMY2B

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Not Available

# Drug_Target_2_General_References:
Not Available

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6967

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
Not Available

# Drug_Target_2_Name:
Alpha-amylase 2B

# Drug_Target_2_Number_of_Residues:
0

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
Not Available

# Drug_Target_2_Protein_Sequence:
Not Available

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
Not Available

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
P19961

# Drug_Target_2_SwissProt_Name:
AMY2B_HUMAN

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
Not Available

# Drug_Target_2_Transmembrane_Regions:
Not Available

#END_DRUGCARD DB03277
